Hereditary Transthyretin-mediated (hATTR) Amyloidosis
1 clinical trials · Condition
◉ Watch Hereditary Transthyretin-mediated (hATTR) Amyloidosis
| Record | Firm | Date |
|---|---|---|
| Patisiran-Lipid Nanoparticle (LNP) Pregnancy Surveillance Program (NCT05040373) | Alnylam Pharmaceuticals | 2020-08-01 |
Track Hereditary Transthyretin-mediated (hATTR) Amyloidosis automatically
Every clearance here is in the API, with alerts when new ones post.